The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1 open-label dose escalation study of the dual SYK/JAK inhibitor cerdulatinib (PRT062070) in patients with relapsed/refractory B-cell malignancies: Safety profile and clinical activity.
 
Ian Flinn
Research Funding - Portola Pharmaceuticals (Inst)
 
Paul A. Hamlin
Honoraria - Genentech/Roche
Consulting or Advisory Role - Gilead Sciences; Pfizer
Research Funding - GlaxoSmithKline (Inst); Janssen (Inst); molecular templates (Inst); Portola Pharmaceuticals (Inst); Seagen (Inst); Spectrum Pharmaceuticals (Inst)
 
Donald K Strickland
Employment - Sarah Cannon Research Institute
 
Anjali Pandey
Employment - Portola Pharmaceuticals
Stock and Other Ownership Interests - Portola Pharmaceuticals
Research Funding - Portola Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Portola Pharmaceuticals
Travel, Accommodations, Expenses - Portola Pharmaceuticals
 
Matt Birrell
Employment - Portola Pharmaceuticals
Stock and Other Ownership Interests - Portola Pharmaceuticals
Travel, Accommodations, Expenses - Portola Pharmaceuticals
 
Greg Coffey
Employment - Portola Pharmaceuticals
Stock and Other Ownership Interests - Portola Pharmaceuticals
Research Funding - Portola Pharmaceuticals
Travel, Accommodations, Expenses - Portola Pharmaceuticals
 
Janet Leeds
Employment - Portola Pharmaceuticals
Travel, Accommodations, Expenses - Portola Pharmaceuticals
 
John T Curnutte
Employment - Portola Pharmaceuticals
Leadership - Portola Pharmaceuticals
Stock and Other Ownership Interests - CV Biosciences; Portola Pharmaceuticals
Research Funding - Portola Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Portola Pharmaceuticals
Travel, Accommodations, Expenses - Portola Pharmaceuticals
 
Jan Andreas Burger
Research Funding - Portola Pharmaceuticals (Inst)
 
Nina D. Wagner-Johnston
Consulting or Advisory Role - Gilead Sciences
Speakers' Bureau - Gilead Sciences
Research Funding - Celgene
 
Manish R. Patel
Honoraria - Lilly; Medivation
Speakers' Bureau - Lilly; Medivation